Clinical Trial Update: Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating toremifene followed by radical prostatectomy in men with stage I or II prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• FARESTON (toremifene citrate)

Snippet

Sponsor: Joel Nelson, MD | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED